Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
FXG vs RSPS: Weighing Factor-Tilted and Equal-Weight Approaches to Consumer Staples

FXG vs RSPS: Weighing Factor-Tilted and Equal-Weight Approaches to Consumer Staples

Key Takeaways

  • FXG and RSPS both deliver U.S. consumer staples exposure but use fundamentally different construction: FXG applies a multi-factor AlphaDEX screening model, while RSPS equal-weights the S&P 500 consumer staples universe.
  • RSPS is the lower-cost fund, charging a 0.40% expense ratio versus 0.63% for FXG, a durable structural advantage for long-term holders.
  • RSPS spreads risk evenly across roughly 37–39 large-cap names, while FXG concentrates more weight in its top 10 holdings, which account for around 40% of assets.
  • FXG tilts toward food producers, beverage makers, and healthcare distribution, whereas RSPS spans household products, tobacco, food retail, and packaged goods more broadly.
  • Both funds carry low market betas (a measure of price sensitivity to the broader market) in the 0.4–0.6 range, reinforcing their defensive profile.
  • Tickeron AI Verdict: RSPS — its lower cost, more balanced diversification, and cleaner single-sector structure give it the edge in this comparison.

Why These Two Staples ETFs Deserve a Closer Look

Consumer staples exchange-traded funds (ETFs) are a common way for investors to add defensive ballast to a portfolio, but not all staples funds are built alike. FXG and RSPS both sit in the same broad sector, yet their indexing approaches produce meaningfully different exposure profiles, cost structures, and risk characteristics. Comparing them is a useful exercise in understanding how weighting methodology — rather than just sector selection — drives relative positioning and fund performance. For investors weighing these two funds, the key question is whether a factor-tilted, slightly more concentrated approach or a straightforward equal-weight approach better suits their goals in the current market environment.

FXG: A Multi-Factor Screening Approach

FXG seeks to track the StrataQuant Consumer Staples Index, a modified equal-dollar-weighted benchmark built using the AlphaDEX screening methodology. Rather than simply capitalizing the sector by market value, the index screens constituents of the Russell 1000 using multiple fundamental factors — including value and growth metrics — to identify stocks that may generate excess returns relative to traditional passive indexes. The fund typically holds around 41 securities, and its top 10 positions represent roughly 40% of net assets, giving it a moderately concentrated profile. Recent top holdings have included Bunge Global (BG), McKesson (MCK), Smithfield Foods (SFD), Pilgrim's Pride (PPC), and Ingredion (INGR). Notably, its factor-driven selection pulls in non-staples names such as healthcare distributors, so the portfolio is not a pure staples sleeve. FXG carries a 0.63% expense ratio and is passively managed but actively screened. I also checked this using Tickeron’s AI Screener to see how the stock selection compares to peers in the space.

RSPS: Straightforward Equal-Weight Exposure

RSPS seeks to replicate the S&P 500 Equal Weight Consumer Staples Index, which equally weights the consumer staples constituents of the S&P 500 as classified under the Global Industry Classification Standard (GICS, the widely used framework for categorizing companies by sector and industry). The fund holds roughly 37–39 names, each representing close to 3% of assets, and rebalances quarterly to restore equal weighting. This structure prevents any single mega-cap from dominating returns and gives smaller constituents a proportionate voice. Recent top holdings have included Kroger (KR), Philip Morris International (PM), Procter & Gamble (PG), Costco Wholesale (COST), and Walmart (WMT). The portfolio is almost entirely consumer defensive, with only a small consumer cyclical sleeve, and it carries a 0.40% expense ratio.

Industry Context and Structural Themes

Consumer staples occupy a defensive niche in equity markets because demand for food, beverages, household goods, and tobacco remains relatively stable across economic cycles. In recent market cycles, elevated inflation, shifting interest-rate expectations, and trade-policy uncertainty have supported demand for defensive sectors with lower beta and steadier cash flows. At the same time, staples companies face margin pressure from input-cost inflation and mixed consumer spending as households trade down or seek value. Structural themes also matter. The rise of weight-loss drugs (often called GLP-1 medications) has pressured packaged-food and snack volumes, while beverage and household-products franchises have proven more resilient. Equal-weight funds such as RSPS capture this breadth evenly, whereas factor-tilted funds like FXG may concentrate in specific sub-industries such as food producers and healthcare distribution, amplifying sub-sector-specific risks and rewards.

Performance Positioning and Cost Considerations

Over recent weeks and months, both funds have behaved as relatively low-volatility defensive vehicles, though their relative positioning has diverged. RSPS has benefited from a more balanced footprint across household-products, beverage, and retail names, which has helped it participate when staples leadership broadened. FXG, by contrast, has been more exposed to food-related and agricultural commodity-linked names, which can amplify sensitivity to commodity trends and consumer taste shifts. Cost is a persistent drag on FXG: its 0.63% expense ratio is notably higher than RSPS's 0.40%, a gap that compounds over time in a sector where total returns are often modest and income-focused. In terms of volatility, both funds show low betas relative to the broad market, but FXG's heavier top-10 concentration introduces greater single-name risk than RSPS's equal-weight structure. For investors prioritizing relative positioning consistency and cost efficiency, RSPS's construction has been comparatively favorable in the current environment.

Using Tickeron’s AI Screener in Practice

In my research process, I often turn to Tickeron’s AI Screener to filter ETFs and stocks by expense ratio, sector exposure, and volatility metrics. It surfaces comparable ideas quickly and helps confirm how different weighting methodologies stack up without manual number-crunching. This kind of tool has become a regular part of my workflow when evaluating defensive sector funds.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FXG, RSPS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FXG sees MACD Histogram crosses below signal line

FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Kroger Co (The) (NYSE:KR), Archer Daniels Midland Company (NYSE:ADM), Constellation Brands (NYSE:STZ).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Consumer Staples Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the consumer staples sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF is 51.47B. The market cap for tickers in the group ranges from 3.09B to 411.62B. KO holds the highest valuation in this group at 411.62B. The lowest valued company is FRPT at 3.09B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was -3%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 2%. TSN experienced the highest price growth at 11%, while BG experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the First Trust Consumer Staples AlphaDEX Fund (FXG) ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 57% and the average quarterly volume growth was 49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 48
Price Growth Rating: 47
SMR Rating: 59
Profit Risk Rating: 69
Seasonality Score: 10 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.